The life sciences hub around Madison and Milwaukee, anchored by biotech firm Promega and the University of Wisconsin system, has diverse capabilities in research instrumentation, reagents, medical devices, and agricultural biotech applications, in addition to drug discovery and stem cells, says Tom Still, president of the Wisconsin Technology Council, a nonprofit economic development group. Read the full story in Chemical & Engineering News here.
- Milwaukee Business Journal: Half a billion dollars in VC funds to converge on Madison to hear state startups pitchSeptember 20, 2019
- InsideWis: Turning early stage rejection into ‘yes’ can depend on supply of cashSeptember 19, 2019
- Recovering from business loss is ex-NFL player’s topic Nov. 6 during Early Stage SymposiumSeptember 18, 2019
- Release: WARF investment fund signals new tack in effort to grow adoption of UW–Madison technologiesSeptember 17, 2019
- Investors will meet with emerging companies at 2019 Wisconsin Early Stage SymposiumSeptember 16, 2019